Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Updated 2010. Available from: http://www.goldcopd.comAccessed March 17, 2011
   Google Scholar
• Centers for Disease Control and Prevention (CDC)Deaths from chronic obstructive pulmonary disease – United States, 2000–2005MMWR Morb Mortal Wkly Rep2008571229123219008792
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC)Summary health statistics for US adults: National Health Interview Survey, 2008Vital and Health Statistics [serial on the Internet]. Series 10242122009 Available from: http://www.cdc.gov/nchs/data/series/sr_10/sr10_242.pdfAccessed May 12, 2010
   Google Scholar
• ThompsonWHSt-HilaireSPrevalence of chronic obstructive pulmonary disease and tobacco use in veterans at Boise veterans affairs medical centerRespir Care20105555556020420725
   PubMed Web of Science ®Google Scholar
• SchneiderKMO’DonnellBEDeanDPrevalence of multiple chronic conditions in the United States’ Medicare populationHealth Qual Life Outcomes200978219737412
   PubMed Web of Science ®Google Scholar
• BarrRGCelliBRManninoDMComorbidities, patient knowledge, and disease management in a national sample of patients with COPDAm J Med200912234835519332230
   PubMed Web of Science ®Google Scholar
• CelliBRMacNeeWATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ ERS position paperEur Respir J200423932946 Erratum in Eur Respir J 2006;27:24215219010
   PubMed Web of Science ®Google Scholar
• FeldmanGSilerTPrasadNEfficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week studyBMC Pulm Med2010101120211002
   PubMed Web of Science ®Google Scholar
• DahlRChungKFBuhlREfficacy of a new once-daily LABA, indacaterol, versus the twice-daily LABA, formoterol, in COPDThorax20106547347920522841
   PubMed Web of Science ®Google Scholar
• DonohueJFFogartyCLötvallJINHANCE Study InvestigatorsOnce-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropiumAm J Respir Crit Care Med201018215516220463178
   PubMed Web of Science ®Google Scholar
• BarnesPJPocockSJMagnussenHIntegrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless designPulm Pharmacol Ther20102316517120080201
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVATS/ERS Task ForceStandardisation of spirometryEur Respir J20052631933816055882
   PubMed Web of Science ®Google Scholar
• CazzolaMMacNeeWMartinezFJAmerican Thoracic Society; European Respiratory Society Task Force on outcomes of COPDOutcomes for COPD pharmacological trials: from lung function to biomarkersEur Respir J20083141646918238951
   PubMed Web of Science ®Google Scholar
• ConnollyCKDiurnal rhythms in airway obstructionBr J Dis Chest197973357366576035
   PubMedGoogle Scholar
• DawkinsKDMuersMFDiurnal variation in airflow obstruction in chronic bronchitisThorax1981366186216458922
   PubMed Web of Science ®Google Scholar
• PettyTLCircadian variations in chronic asthma and chronic obstructive pulmonary diseaseAm J Med19888521233400684
   PubMed Web of Science ®Google Scholar
• CalverleyPMLeeATowseLvan NoordJWitekTJKelsenSEffect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary diseaseThorax20035885586014514937
   PubMed Web of Science ®Google Scholar
• RamsdaleEHMorrisMMHargreaveFEInterpretation of the variability of peak flow rates in chronic bronchitisThorax1986417717763538479
   PubMed Web of Science ®Google Scholar
• MeursHPostmaDSKoëterGHThe beta-adrenergic system of non-allergic patients with chronic airflow obstruction and early morning dyspnoeaAnn Allergy1987594174212827542
   PubMedGoogle Scholar
• PartridgeMRKarlssonNSmallIRPatient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet surveyCurr Med Res Opin2009252043204819569976
   PubMed Web of Science ®Google Scholar
• CasaburiRMahlerDAJonesPWA long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J20021921722411866001
   PubMed Web of Science ®Google Scholar
• BrusascoVHodderRMiravitllesMKorduckiLTowseLKestenSHealth outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax200358399404 Erratum in Thorax 2005;60:10512728159
   PubMed Web of Science ®Google Scholar
• DusserDBravoMLIaconoPThe effect of tiotropium on exacerbations and airflow in patients with COPDEur Respir J200627547555 Erratum in Eur Respir J 2006;27:107616507855
   PubMed Web of Science ®Google Scholar
• DonohueJFvan NoordJABatemanEDA 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterolChest2002122475512114338
   PubMed Web of Science ®Google Scholar
• BriggsDDJrCovelliHLapidusRBhattycharyaSKestenSCassinoCImproved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPDPulm Pharmacol Ther20051839740416179215
   PubMed Web of Science ®Google Scholar
• KornmannODahlRCentanniSfor INLIGHT-2 (Indacaterol Efficacy Evaluation Using 150-μg Doses with COPD Patients) study investigatorsOnce-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparisonEur Respir J20113727327920693243
   PubMed Web of Science ®Google Scholar
• ChapmanKRRennardSIDograAOwenRLassenCKramerBLong-term safety and efficacy of indacaterol, a novel long-acting β2-agonist, in subjects with COPD: a randomized, placebo-controlled studyChest2011140687521349928
   PubMed Web of Science ®Google Scholar
• TsagarakiVAmfilochiouAMarkantonisSLEvidence of tachyphylaxis associated with salmeterol treatment of chronic obstructive pulmonary disease patientsInt J Clin Pract20066041542116620353
   PubMed Web of Science ®Google Scholar
• CalverleyPMBoonsawatWCsekeZZhongNPetersonSOlssonHMaintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J200322912919 Erratum in Eur Respir J 2004;24:107514680078
   PubMed Web of Science ®Google Scholar
• PartridgeMRMiravitllesMStåhlEKarlssonNSvenssonKWelteTDevelopment and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPDEur Respir J2010369610419897551
   PubMed Web of Science ®Google Scholar
• BuhlRDunnLJDisdierCBlinded 12-week comparison of oncedaily indacaterol and tiotropium in COPDEur Respir J2011 epub ahead of print doi: http://dx.doi.org/10.1183/09031936.00191810
   Web of Science ®Google Scholar
• KornSKerwinEAtisSAmosCOwenRLassenCfor the INSIST study groupIndacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week studyRespir Med201110571972621367594
   PubMed Web of Science ®Google Scholar
• RandCSNidesMCowlesMKWiseRAConnettJLong-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research GroupAm J Respir Crit Care Med19951525805887633711
   PubMed Web of Science ®Google Scholar
• JamesPNAndersonJBPriorJGWhiteJPHenryJACochraneGMPatterns of drug taking in patients with chronic airflow obstructionPostgrad Med J1985617102859583
   PubMed Web of Science ®Google Scholar
• CordenZMBosleyCMReesPJCochraneGMHome nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of lifeChest1997112127812829367468
   PubMed Web of Science ®Google Scholar
• ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther2001231296131011558866
   PubMed Web of Science ®Google Scholar
• Breekveldt-PostmaNSKoerselmanJErkensJALammersJWHeringsRMEnhanced persistence with tiotropium compared with other respiratory drugs in COPDRespir Med20071011398140517368011
   PubMed Web of Science ®Google Scholar
• TamuraGOhtaKAdherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patchRespir Med20071011895190217587559
   PubMed Web of Science ®Google Scholar
• BourbeauJBartlettSJPatient adherence in COPDThorax20086383183818728206
   PubMed Web of Science ®Google Scholar